SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001557142-21-000020
Filing Date
2021-03-04
Accepted
2021-03-04 16:02:36
Documents
14
Period of Report
2021-03-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kdmn-20210304x8k.htm   iXBRL 8-K 84127
2 EX-99.1 kdmn-20210304xex99_1.htm EX-99.1 200428
3 GRAPHIC kdmn-20210304xex99_1g001.jpg GRAPHIC 14972
  Complete submission text file 0001557142-21-000020.txt   443715

Data Files

Seq Description Document Type Size
4 EX-101.SCH kdmn-20210304.xsd EX-101.SCH 3069
5 EX-101.LAB kdmn-20210304_lab.xml EX-101.LAB 15500
6 EX-101.PRE kdmn-20210304_pre.xml EX-101.PRE 11473
7 EXTRACTED XBRL INSTANCE DOCUMENT kdmn-20210304x8k_htm.xml XML 4765
Mailing Address 450 EAST 29TH STREET NEW YORK NY 10016
Business Address 450 EAST 29TH STREET NEW YORK NY 10016 833-900-5366
Kadmon Holdings, Inc. (Filer) CIK: 0001557142 (see all company filings)

IRS No.: 273576929 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37841 | Film No.: 21714091
SIC: 2834 Pharmaceutical Preparations